Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
IPO Year:
Exchange: NYSE
Website: humana.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/6/2024 | $247.00 → $308.00 | Underperform → Neutral | BofA Securities |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 10/8/2024 | $308.00 | Mkt Perform → Outperform | Bernstein |
| 10/7/2024 | $402.00 → $261.00 | Buy → Hold | TD Cowen |
| 10/7/2024 | $519.00 → $253.00 | Buy → Hold | Jefferies |
| 10/3/2024 | $392.00 → $274.00 | Overweight → Neutral | Piper Sandler |
| 10/2/2024 | $376.00 → $247.00 | Neutral → Underperform | BofA Securities |
| 10/2/2024 | $400.00 → $250.00 | Outperform → Market Perform | Leerink Partners |
| 10/2/2024 | $400.00 → $250.00 | Overweight → Equal-Weight | Stephens |
| 6/26/2024 | $392.00 | Overweight | Piper Sandler |
BofA Securities upgraded Humana from Underperform to Neutral and set a new price target of $308.00 from $247.00 previously
KeyBanc Capital Markets initiated coverage of Humana with a rating of Sector Weight
Bernstein upgraded Humana from Mkt Perform to Outperform and set a new price target of $308.00
TD Cowen downgraded Humana from Buy to Hold and set a new price target of $261.00 from $402.00 previously
Jefferies downgraded Humana from Buy to Hold and set a new price target of $253.00 from $519.00 previously
Piper Sandler downgraded Humana from Overweight to Neutral and set a new price target of $274.00 from $392.00 previously
BofA Securities downgraded Humana from Neutral to Underperform and set a new price target of $247.00 from $376.00 previously
Leerink Partners downgraded Humana from Outperform to Market Perform and set a new price target of $250.00 from $400.00 previously
Stephens downgraded Humana from Overweight to Equal-Weight and set a new price target of $250.00 from $400.00 previously
Piper Sandler initiated coverage of Humana with a rating of Overweight and set a new price target of $392.00
Leading health and well-being company Humana Inc. (NYSE:HUM) announced today that it has named Michelle O'Hara as Chief Human Resources Officer, effective January 1, 2025. O'Hara will oversee the enterprise talent strategy and people programs for Humana's more than 63,000 employees. She brings a proven track record of transforming HR capabilities and enabling companies to effectively attract, recruit, develop and retain a talented and diverse workforce. O'Hara will report directly to Humana President and CEO Jim Rechtin. "Humana's people strategy is a core capability for our business that supports and empowers our workforce so they can successfully deliver on our mission to make it easier
Humana Inc. (NYSE:HUM) has been recognized by both Military Times and Military Friendly® as a top employer for veterans and military families. Military Times, a leading source for independent news and information for service members and their families, ranked Humana #14 in its Healthcare category on its 2024 Best for Vets: Employers list. Now in its 15th year, Military Times Best for Vets rankings are based on a voluntary survey covering policies and practices that make companies attractive to the military community. Recruitment and employment practices, as well as retention and support programs, are given the most weight and importance in scoring and final rankings. Military Friendly®,
Partnership Focuses on Improving Prior Authorization Process, Helping Drive Better Patient Outcomes Humana Inc. (NYSE:HUM) and Evolent Health, Inc. (NYSE:EVH) announced they have expanded their strategic medical oncology partnership to modernize and streamline prior authorization processes to include radiation and surgical oncology services. By connecting all primary approaches to treating cancer, this collaboration will help expedite approval of prior authorization requests, improve patient access to care, and ensure timely access to critical treatments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241107578119/en/ "This part
Reports 3Q24 earnings per share (EPS) of $3.98 on a GAAP basis, Adjusted EPS of $4.16; reports YTD 2024 EPS of $15.72 on a GAAP basis, $18.35 on an Adjusted basis Updates FY 2024 EPS guidance to 'at least $12.89' on a GAAP basis, 'at least $16.00' on an Adjusted basis; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 40,000 to now anticipate annual growth of approximately 265,000, or approximately 5 percent Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9:00 a.m. ET question and answer session to discuss its financial results for
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on January 31, 2025 to stockholders of record as of the close of business on December 31, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, milita
Humana Inc. (NYSE:HUM), a leading health and well-being company, and Longevity Health, a clinical services company dedicated to serving vulnerable individuals living in a long-term care facility, have announced that eligible residents of long-term care facilities in Indiana, Iowa, Kentucky, Louisiana, New Mexico, Tennessee, Washington, and West Virginia will have access to Humana Together in Health, a Medicare Advantage Institutional Special Needs Plan (I-SNP), starting in 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241024685387/en/ Humana Together in Health – currently available in Georgia, South Carolina, Texas, Virgin
Humana Inc. (NYSE:HUM) announced today that Gordon Smith has been elected as a member of the Company's Board of Directors. Smith serves as an Operating Advisor of Clayton, Dubilier & Rice LLC (CD&R) Funds, a leading private investment firm. He was previously Co-President and Co-Chief Operating Officer of JPMorgan Chase & Co. (JPMorgan), where he was a member of the firm's Operating Committee and helped oversee all aspects of the company's business and operations from 2018 until his retirement in January of 2022. His career at JPMorgan began in 2007 and spanned 15 years, during which he also served as Chief Executive Officer of Consumer and Community Banking from 2012 to 2021. Prior to JPMo
Food drive benefits communities across the nation CenterWell Home Health, one of America's leading providers of home health, has collected nearly 90,000 meals in its 20th annual food drive to feed people in the communities it serves around the country. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241023010488/en/Employees of CenterWell Home Health's Parkersburg, W.Va., branch, which collected the largest amount of food and monetary donations in this year's food drive (left to right): Jackie Benton, RN, branch director; Sara Harrington, RN, clinical assessment advisor; Debra Harber, LPN; Abbi Sturm, OT, clinical liaison; Janet
The former Fortune 50 CEO joins Define to further drive transformational change in healthcare at the earliest stages of innovation SAN FRANCISCO, Oct. 22, 2024 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Bruce Broussard, former CEO and president of Humana (NYSE:HUM), has joined the firm as venture partner. Bruce will play a pivotal role at Define, leveraging his invaluable experience scaling companies and fostering innovation within private startups, mid-size companies, and the Fortune 50. He will partner closely with Define founders to scale their businesses and become category-defining companie
Humana Inc. (NYSE:HUM) has been recognized by the Hispanic Association on Corporate Responsibility (HACR) in their 2024 Corporate Inclusion Index (CII) for its continued commitment to advancing inclusion for Hispanic and Latinx employees in the C-suite, corporate boardroom, supplier base, mid- and entry-level employee pipeline and philanthropic sphere. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241017880579/en/Humana Inc. CEO Jim Rechtin (far left) and Unidos Network Resource Group members at the company's 2024 DEI Day event. (Photo: Business Wire) The Corporate Inclusion Index is a research initiative that measures Hispanic
Reports 3Q24 earnings per share (EPS) of $3.98 on a GAAP basis, Adjusted EPS of $4.16; reports YTD 2024 EPS of $15.72 on a GAAP basis, $18.35 on an Adjusted basis Updates FY 2024 EPS guidance to 'at least $12.89' on a GAAP basis, 'at least $16.00' on an Adjusted basis; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 40,000 to now anticipate annual growth of approximately 265,000, or approximately 5 percent Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9:00 a.m. ET question and answer session to discuss its financial results for
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on January 31, 2025 to stockholders of record as of the close of business on December 31, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, milita
Humana Inc. (NYSE:HUM) will release its financial results for the third quarter 2024 (3Q24), as well as prepared management remarks (in PDF format), on Wednesday, October 30, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI66effa11b1e4494d907df29b87d7d237. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on October 25, 2024 to stockholders of record as of the close of business on September 30, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, mil
Reports 2Q24 earnings per share (EPS) of $5.62 on a GAAP basis, Adjusted EPS of $6.96; reports YTD 2024 EPS of $11.74 on a GAAP basis, $14.19 on an Adjusted basis Revises FY 2024 EPS guidance to 'approximately $12.81' (previously 'approximately $13.93') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 75,000 to now anticipate annual growth of approximately 225,000, or 4.2 percent Publishes Letter from the CEO and prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9:00
Humana Inc. (NYSE:HUM) will release its financial results for the second quarter 2024 (2Q24), as well as prepared management remarks (in PDF format), on Wednesday, July 31, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI4837b56336d1453fb10a8fdaada5e1c0. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi
Reports 1Q24 earnings per share (EPS) of $6.11 on a GAAP basis, Adjusted EPS of $7.23 Revises FY 2024 EPS guidance to 'approximately $13.93' (previously 'approximately $14.87') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 50,000 to now anticipate annual growth of approximately 150,000, or 2.8 percent Continues successful track record of organic expansion in Medicaid with recent contract wins in Florida, Texas, and Virginia Publishes prepared management remarks to Investor Relations page of www.humana.com ah
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 26, 2024 to stockholders of record as of the close of business on June 28, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military se
Humana Inc. (NYSE:HUM) will release its financial results for the first quarter 2024 (1Q24), as well as prepared management remarks (in PDF format), on Wednesday, April 24, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI6d7513be1a494bbb82b4b8caa62d3b2f. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 26, 2024 to stockholders of record as of the close of business on March 29, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military
4 - HUMANA INC (0000049071) (Issuer)
3 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
10-Q - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
10-Q - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
11-K - HUMANA INC (0000049071) (Filer)
11-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
4 - HUMANA INC (0000049071) (Issuer)
Leading health and well-being company Humana Inc. (NYSE:HUM) announced today that it has named Michelle O'Hara as Chief Human Resources Officer, effective January 1, 2025. O'Hara will oversee the enterprise talent strategy and people programs for Humana's more than 63,000 employees. She brings a proven track record of transforming HR capabilities and enabling companies to effectively attract, recruit, develop and retain a talented and diverse workforce. O'Hara will report directly to Humana President and CEO Jim Rechtin. "Humana's people strategy is a core capability for our business that supports and empowers our workforce so they can successfully deliver on our mission to make it easier
The former Fortune 50 CEO joins Define to further drive transformational change in healthcare at the earliest stages of innovation SAN FRANCISCO, Oct. 22, 2024 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Bruce Broussard, former CEO and president of Humana (NYSE:HUM), has joined the firm as venture partner. Bruce will play a pivotal role at Define, leveraging his invaluable experience scaling companies and fostering innovation within private startups, mid-size companies, and the Fortune 50. He will partner closely with Define founders to scale their businesses and become category-defining companie
David Dintenfass to lead new centralized function focused on customer experience, sales and marketing Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today that it has named David Dintenfass as President of Enterprise Growth. In this new role, Dintenfass will have responsibility for leading the company's growth plan with a primary focus on customer acquisition, retention, and experience. The creation of this position, and its emphasis on the customer and digital experience, will help Humana deliver on its long-term strategy and maximize long-term growth within the Medicare Advantage market. By 2030, one in five Americans is projected to be 65 years
Broussard, who reimagined senior-focused health care, announces he will step down after more than a decade of serving at the helm of the company Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today it has named health care industry veteran Jim Rechtin as President and Chief Operating Officer of Humana Inc., effective January 8, 2024, as part of a long-planned CEO transition. He will report to Bruce Broussard, CEO, until the latter half of 2024 at which time Broussard will step down and Rechtin will assume the CEO role. Broussard joined Humana in 2011 and assumed the role of CEO in 2013. Over the last decade, he has led the company's transformati
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE:HUM) for the past 41 years, today announced that David A. Jones Jr. has been elected to serve as Chairman of the Board of Directors, effective as of April 1, 2023. Jones is a current board member with over 26 years of dedicated service to the Humana Foundation. Since 1993, Jones has served on the Board of Directors for Humana Inc., a position from which he recently decided to retire as of April 20, 2023. "I am beyond honored with the opportunity to lead the Humana Foundation board and to further the 40-year history of the Foundation in Louisville, Kentucky and beyond as the foundation's reach has expanded nationally," said Mr.
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
Builds On Ongoing Collaboration With Google Health To Develop Population Health Solutions And Address Healthcare Challenges
TD Cowen analyst Gary Taylor maintains Humana (NYSE:HUM) with a Buy and raises the price target from $396 to $407.
Cantor Fitzgerald analyst Sarah James reiterates Humana (NYSE:HUM) with a Neutral and maintains $360 price target.
Healthcare investors are expecting Republican presidential nominee Donald Trump to ease regulations on Medicare Advantage if the former president wins and returns to the White House. Under the Biden administration, the Centers for Medicare & Medicaid Services has hardened its stance on the program after it faced criticism for insurers overbilling the government and denying care to seniors too many times, the Wall Street Journal reported. Republicans tend to favor privatizing government services and have been friendlier to Medicare Advantage plans, a trend that investors are betting could continue under a second Trump administration. Also Read: UnitedHealth Analysts Boost Their Fore
Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by attrition in Medicaid membership, partially offset by higher premium yields reflecting the medical cost trend and growth in CarelonRx product revenue related to members served. Related: Morgan Stanley Says Elevance Health’s Growth Attributed To Consistent Performance But Undervalued. Premiums fell 3.2% to $35.42 billion, and product revenue rose 14% to $5.53 billion. Services fees increased 18% to $2.28 billion. “Second quarter results reflect the power of our diversified business and thoughtful
In the preceding three months, 11 analysts have released ratings for Humana (NYSE:HUM), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 7 0 0 Last 30D 0 0 1 0 0 1M Ago 0 1 1 0 0 2M Ago 0 0 3 0 0 3M Ago 1 2 2 0 0 In the assessment of 12-month price targets, analysts unveil insights for Humana, presenting an average target of $369.64, a high estimate of $400.00, and a low estimate of $326.00. A 2.18% drop is evident in the curren
Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the price target from $355 to $400.
Humana (NYSE:HUM) has outperformed the market over the past 20 years by 8.18% on an annualized basis producing an average annual return of 16.6%. Currently, Humana has a market capitalization of $45.73 billion. Buying $100 In HUM: If an investor had bought $100 of HUM stock 20 years ago, it would be worth $2,206.34 today based on a price of $379.49 for HUM at the time of writing. Humana's Performance Over Last 20 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and reviewed by an